Hyperthyroidism in Pediatric Patients in a University Hospital: Ten Years of Experience

Z. Kocabey Sütçü, Beray Selver Eklioğlu, M. Atabek
{"title":"Hyperthyroidism in Pediatric Patients in a University Hospital: Ten Years of Experience","authors":"Z. Kocabey Sütçü, Beray Selver Eklioğlu, M. Atabek","doi":"10.4274/jpea.2024.277","DOIUrl":null,"url":null,"abstract":"Although rare in childhood, hyperthyroidism is diagnosed by suppressed serum thyrotropin (TSH) levels and increased levels of free triiodothyronin (fT3) and free thyroxine (fT4) in addition to history and physical examination findings. In this study, we aimed to investigate the causes of hyperthyroidism and the clinical features of the disease in children and to evaluate the treatment. A total of 39 patients with hyperthyroidism diagnosed between 2010 and 2019 in the pediatric endocrinology department were included in the study.Thirty-one (79.5%) patients were female, and the mean age of admission was 14.4 (4.3-17.5) years. Of the cases, 33 (84.6%) were diagnosed with Graves’ diseases and 6 (16.7%) with Hashimoto thyroiditis. The most frequent complaints of patients diagnosed with hyperthyroidism were irritability (24, 61.5%), palpitation (22, 56.9%), and sweating (21, 53.8%). The most frequent findings were goiter in 31 (79.5%) patients and tachycardia in 27 (69.2%) patients. Serum TSH levels were suppressed in all patients, fT3 levels were increased in 94.4% of them, and fT4 levels were increased in 80.5% of them. In patients with Graves’ disease, TSH receptor antagonist was positive in 31 (93.9%) cases, and at least one of the thyroid autoantibodies was positive in all patients. Antithyroid drug treatment was initiated in all patients; 35 of them received methimazole and 4 of them received propylthiouracil. Radioactive iodine treatment was applied to three patients, and two patients were treated surgically who did not respond to antithyroid drug treatment. Antithyroid drug adverse effects were observed in 7 (21.2%) patients, requiring drug discontinuation in 1 patient. Although hyperthyroidism is rare in childhood, its treatment is difficult and requires close follow-up. Treatment options are different for adult patients. There is a need for multicenter studies to evaluate treatment efficacy and long-term outcomes in children.","PeriodicalId":509964,"journal":{"name":"The Journal of Pediatric Academy","volume":"47 23","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Pediatric Academy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/jpea.2024.277","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Although rare in childhood, hyperthyroidism is diagnosed by suppressed serum thyrotropin (TSH) levels and increased levels of free triiodothyronin (fT3) and free thyroxine (fT4) in addition to history and physical examination findings. In this study, we aimed to investigate the causes of hyperthyroidism and the clinical features of the disease in children and to evaluate the treatment. A total of 39 patients with hyperthyroidism diagnosed between 2010 and 2019 in the pediatric endocrinology department were included in the study.Thirty-one (79.5%) patients were female, and the mean age of admission was 14.4 (4.3-17.5) years. Of the cases, 33 (84.6%) were diagnosed with Graves’ diseases and 6 (16.7%) with Hashimoto thyroiditis. The most frequent complaints of patients diagnosed with hyperthyroidism were irritability (24, 61.5%), palpitation (22, 56.9%), and sweating (21, 53.8%). The most frequent findings were goiter in 31 (79.5%) patients and tachycardia in 27 (69.2%) patients. Serum TSH levels were suppressed in all patients, fT3 levels were increased in 94.4% of them, and fT4 levels were increased in 80.5% of them. In patients with Graves’ disease, TSH receptor antagonist was positive in 31 (93.9%) cases, and at least one of the thyroid autoantibodies was positive in all patients. Antithyroid drug treatment was initiated in all patients; 35 of them received methimazole and 4 of them received propylthiouracil. Radioactive iodine treatment was applied to three patients, and two patients were treated surgically who did not respond to antithyroid drug treatment. Antithyroid drug adverse effects were observed in 7 (21.2%) patients, requiring drug discontinuation in 1 patient. Although hyperthyroidism is rare in childhood, its treatment is difficult and requires close follow-up. Treatment options are different for adult patients. There is a need for multicenter studies to evaluate treatment efficacy and long-term outcomes in children.
一家大学医院儿科患者的甲状腺功能亢进症:十年经验
甲状腺功能亢进症虽然在儿童期很少见,但除了病史和体格检查结果外,血清促甲状腺激素(TSH)水平受抑制、游离三碘甲状腺原氨酸(fT3)和游离甲状腺素(fT4)水平升高也可诊断甲状腺功能亢进症。本研究旨在探究儿童甲状腺功能亢进症的病因和临床特征,并对治疗方法进行评估。研究共纳入了39例2010年至2019年期间在儿科内分泌科确诊的甲亢患者。31例(79.5%)患者为女性,平均入院年龄为14.4(4.3-17.5)岁。其中,33例(84.6%)被诊断为巴塞杜氏病,6例(16.7%)被诊断为桥本氏甲状腺炎。确诊为甲状腺功能亢进症的患者最常见的主诉是烦躁(24 人,61.5%)、心悸(22 人,56.9%)和出汗(21 人,53.8%)。最常见的检查结果是甲状腺肿(31 例,占 79.5%)和心动过速(27 例,占 69.2%)。所有患者的血清促甲状腺激素(TSH)水平均受到抑制,94.4%的患者fT3水平升高,80.5%的患者fT4水平升高。在巴塞杜氏病患者中,有31人(93.9%)的促甲状腺激素受体拮抗剂呈阳性,所有患者至少有一种甲状腺自身抗体呈阳性。所有患者都接受了抗甲状腺药物治疗,其中35人接受了甲巯咪唑治疗,4人接受了丙基硫氧嘧啶治疗。3名患者接受了放射性碘治疗,2名对抗甲状药物治疗无效的患者接受了手术治疗。7名患者(21.2%)出现了抗甲状腺药物不良反应,其中1名患者需要停药。虽然甲状腺功能亢进症在儿童期很少见,但其治疗难度很大,需要密切随访。成人患者的治疗方案有所不同。有必要进行多中心研究,以评估儿童的治疗效果和长期预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信